NVDA+0.84%AAPL−2.51%GOOGL−1.17%MSFT−2.04%AMZN−0.15%TSM+2.85%SPCX−1.20%AVGO+0.21%
StockVS

NASDAQ · USD

Jasper Therapeutics, Inc. (JSPRW) Stock Analysis

Jasper Therapeutics, Inc. (JSPRW) is a stock listed on NASDAQ and quoted in US Dollar.

JSPRW

$0.01

+$0.00 (+2.22%)

Sep 1, 2026 · Market close

This is a derivative instrument — a warrant on Jasper Therapeutics, Inc. (JSPR) common stock.

Issuer fundamentals are shown on the issuer page, not here.

View JSPR →

Price History

Hover for the daily close. The dotted line marks the period open.

JSPRW Key Statistics

As of Sep 1, 2026
Trading
Open
$0.08
Previous Close
$0.01
BetaHow much the share price moves relative to the wider market. 1.0 moves in line with it; above 1.0 swings more, below 1.0 less.
3.04

Only metrics the company reports are shown. Data provided by Yahoo Finance via yfinance. Updated daily.

About Jasper Therapeutics, Inc.

Jasper Therapeutics, Inc., a clinical-stage biotechnology company, focuses on developing therapeutics targeting mast stem cell driven diseases in the United States. The company's lead product candidate is briquilimab, a monoclonal antibody designed to block stem cell factors from binding to and signaling through the CD117 receptor on mast and stem cells. It focuses on the development and commercialization of therapeutic agents for patients with various mast cell driven diseases, including chronic spontaneous urticaria, chronic inducible urticaria, and asthma. Jasper Therapeutics, Inc. was founded in 2018 and is headquartered in Redwood City, California.

Visit website →